(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 21.64% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 6.9%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.51%.
Evolent Health's revenue in 2026 is $2,097,018,000.On average, 17 Wall Street analysts forecast EVH's revenue for 2026 to be $300,059,475,090, with the lowest EVH revenue forecast at $276,995,370,750, and the highest EVH revenue forecast at $316,905,316,005. On average, 17 Wall Street analysts forecast EVH's revenue for 2027 to be $373,548,042,840, with the lowest EVH revenue forecast at $318,375,087,360, and the highest EVH revenue forecast at $410,631,504,720.
In 2028, EVH is forecast to generate $418,997,895,510 in revenue, with the lowest revenue forecast at $384,288,679,665 and the highest revenue forecast at $459,925,374,780.